Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Entheon Biomedical Announces Non-Brokered Private Placement Financing

Entheon Biomedical Announces Non-Brokered Private Placement Financing

  • Post published:April 5, 2022
  • Post category:Press Release
Read more about the article Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform

  • Post published:March 29, 2022
  • Post category:Press Release
Read more about the article Entheon Biomedical Announces Enrollment in Phase 1 Study of DMT

Entheon Biomedical Announces Enrollment in Phase 1 Study of DMT

  • Post published:March 15, 2022
  • Post category:Press Release
Read more about the article Entheon Biomedical Announces EBIQ-101 First-Patient Dose

Entheon Biomedical Announces EBIQ-101 First-Patient Dose

  • Post published:February 24, 2022
  • Post category:Press Release
Read more about the article Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study

Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study

  • Post published:February 16, 2022
  • Post category:Press Release
Read more about the article Entheon Biomedical Announces the Approval of DMT Clinical Trial

Entheon Biomedical Announces the Approval of DMT Clinical Trial

  • Post published:February 3, 2022
  • Post category:Press Release
Read more about the article Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today

Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today

  • Post published:January 18, 2022
  • Post category:Press Release
Read more about the article Entheon Biomedical Corp. Files Preliminary Shelf Prospectus

Entheon Biomedical Corp. Files Preliminary Shelf Prospectus

  • Post published:January 18, 2022
  • Post category:Press Release
Read more about the article Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee

Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee

  • Post published:January 6, 2022
  • Post category:Press Release
Read more about the article Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel

  • Post published:December 21, 2021
  • Post category:Press Release

End of content

No more pages to load

Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More